JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 5,970.00
+10.00 (0.17%)
At close: Dec 5, 2025
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 214.96 billion as of December 5, 2025. Its market cap has decreased by -37.21% in one year.
Market Cap
214.96B
Enterprise Value
321.04B
Revenue
75.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,970.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 214.96B, an increase of 66.50%. That is a compound annual growth rate of 8.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 214.96B | -22.49% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | 402.27B | 139.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |